Cargando…

5.4 BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY

BACKGROUND: Current diagnostic models of psychosis have been questioned since Kraepelin’s original dichotomy of dementia praecox and manic depression. Indeed, increasing evidence has suggested that a dimensional approach might be a valid alternative platform for research. However, while an increasin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quattrone, Diego, Sham, Pak, Vassos, Evangelos, Gayer-Anderson, Charlotte, Tripoli, Giada, Ferraro, Laura, O’Donovan, Michael, Richards, Alex, van Os, Jim, Morgan, Craig, Reininghaus, Ulrich, Murray, Robin, Forti, Marta Di, Lewis, Cathryn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887566/ http://dx.doi.org/10.1093/schbul/sby014.016

Ejemplares similares

T170. GENE AND ENVIRONMENT INTERPLAY AMONG DIAGNOSTIC CATEGORIES IN THE EUGEI STUDY
por: Rodriguez, Victoria, et al.
Publicado: (2020)

T110. FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS
por: Quattrone, Diego, et al.
Publicado: (2018)

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study
por: Quattrone, Diego, et al.
Publicado: (2019)

S118. TRANSDIAGNOSTIC SYMPTOM DIMENSIONS OF PSYCHOSIS AND THE PREDICTIVE ROLE OF PREMORBID ADJUSTMENT AND COGNITIVE CHARACTERISTICS IN THE MULTINATIONAL EU-GEI STUDY
por: Ferraro, Laura, et al.
Publicado: (2020)

S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
por: Quattrone, Diego, et al.
Publicado: (2020)

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
por: Quattrone, Diego, et al.
Publicado: (2021)

The transdiagnostic dimension of psychosis: implications for psychiatric nosology and research
por: VAN OS, Jim
Publicado: (2015)

The Maudsley environmental risk score for psychosis
por: Vassos, Evangelos, et al.
Publicado: (2020)

35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS
por: Murray, Robin, et al.
Publicado: (2018)

O12.4. SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE
por: Di Forti, Marta, et al.
Publicado: (2018)

S77. JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IMPAIRMENT IN FIRST EPISODE PSYCHOSIS ACROSS EUROPE
por: Tripoli, Giada, et al.
Publicado: (2018)

S92. REASONS TO START SMOKING CANNABIS: A CASE CONTROL-ANALYSIS FROM THE EUGEI STUDY
por: Spinazzola, Edoardo, et al.
Publicado: (2020)

T52. COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY
por: Tripoli, Giada, et al.
Publicado: (2020)

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study
por: Ferraro, Laura, et al.
Publicado: (2021)

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study
por: Rodriguez, Victoria, et al.
Publicado: (2023)

O2.1. FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS
por: Ferraro, Laura, et al.
Publicado: (2018)

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study
por: Quattrone, Diego, et al.
Publicado: (2021)

F99. FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS EUROPE AND BRAZIL
por: Cascia, Caterina La, et al.
Publicado: (2018)

F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY
por: Rodriguez, Victoria, et al.
Publicado: (2018)

Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Findings from the EUGEI study
por: Fusar-Poli, L., et al.
Publicado: (2023)

First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data
por: Ferraro, Laura, et al.
Publicado: (2022)

Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: the EU-GEI study
por: Aas, Monica, et al.
Publicado: (2023)

The association between exposome score for schizophrenia and metabolic parameters in individuals with schizophrenia and healthy controls: Findings from the EUGEI study
por: Erzin, G., et al.
Publicado: (2023)

Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
por: Erzin, Gamze, et al.
Publicado: (2021)

Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study
por: Tripoli, Giada, et al.
Publicado: (2021)

Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case–Control Study
por: Tripoli, Giada, et al.
Publicado: (2022)

Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study
por: Ajnakina, Olesya, et al.
Publicado: (2021)

Transdiagnostic Dimensions of Psychiatric Comorbidity in Individuals at Clinical High Risk for Psychosis: A Preliminary Study Informed by HiTOP
por: Cowan, Henry R., et al.
Publicado: (2021)

Higher-Order Dimensions of Psychopathology in a Neurodevelopmental Transdiagnostic Sample
por: Holmes, Joni, et al.
Publicado: (2021)

Linking cerebellar functional gradients to transdiagnostic behavioral dimensions of psychopathology
por: Dong, Debo, et al.
Publicado: (2022)

Mapping behavioural, cognitive and affective transdiagnostic dimensions in frontotemporal dementia
por: Ramanan, Siddharth, et al.
Publicado: (2023)

Resurrection of the Follow-Back Method to Study the Transdiagnostic Origins of Psychosis: Comment on: “Timing, Distribution, and Relationship Between Nonpsychotic and Subthreshold Psychotic Symptoms Prior to Emergence of a First Episode of Psychosis”, by Cupo et al.
por: van Os, Jim, et al.
Publicado: (2021)

5.3 EVIDENCE ON A TRANSDIAGNOSTIC PSYCHOSIS SPECTRUM OF SCHIZOPHRENIA, SCHIZOAFFECTIVE AND PSYCHOTIC BIPOLAR DISORDER IN THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP)
por: Reininghaus, Ulrich, et al.
Publicado: (2018)

Corticospinal tract abnormalities and ventricular dilatation: A transdiagnostic comparative tractography study
por: Sarica, Alessia, et al.
Publicado: (2021)

Prospects for using risk scores in polygenic medicine
por: Lewis, Cathryn M., et al.
Publicado: (2017)

Polygenic risk scores: from research tools to clinical instruments
por: Lewis, Cathryn M., et al.
Publicado: (2020)

Migration history and risk of psychosis: results from the multinational EU-GEI study
por: Tarricone, Ilaria, et al.
Publicado: (2022)

9. DOES BIOLOGY READ THE DSM? TRANSDIAGNOSTIC FINDINGS IN PSYCHOSIS AND IMPLICATIONS FOR TREATMENT
por: Owen, Michael
Publicado: (2018)

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
por: Di Forti, Marta, et al.
Publicado: (2019)

F220. THREAT ANTICIPATION AND NEGATIVE AFFECT IN EARLY PSYCHOSIS
por: Chavez-Baldini, UnYoung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_12r9i9aqohnur50a47hjv1flnr